Recombinant CD37 (Otlertuzumab Biosimilar) antibody
The Humanized Monoclonal anti-CD37 (Otlertuzumab Biosimilar) antibody (ABIN7538065) specifically detects CD37 (Otlertuzumab Biosimilar) in ELISA and WB.
The antibody is reactive with Human samples.
Catalog No. ABIN7538065
$323.13
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant CD37 (Otlertuzumab Biosimilar) antibody (ABIN7538065)
Target
CD37 (Otlertuzumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Application
ELISA, Western Blotting (WB)
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Otlertuzumab Biosimilar - Anti-CD37, TSPAN26 mAb - Research Grade
-
Characteristics
- Antibody Type: VH-V-kappa-CH2-CH3
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Purity
- > 85%
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS buffer PH7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- CD37 (Otlertuzumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
- Otlertuzumab is a humanized anti-CD37 monoclonal antibody that can be used for cancer research.
-
CAS-No
- 1372645-37-8
Target
-
You are here:
